SCHEMBL6422765

SCHEMBL6422765

Cc1cc(Oc2ccc(Oc3cccc(Oc4cccc(F)c4)c3)cc2)c(C)c(Oc2ccc(Oc3cccc(Oc4cccc(F)c4)c3)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.49
SLC6A4 P31645 5/20 0.49
SLC6A3 Q01959 4/20 0.49
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
GAA P10253 2/20 0.42
MEN1 O00255 1/20 0.42
MITF O75030 1/20 0.42
MAPT P10636 1/20 0.42
GFER P55789 1/20 0.42
KMT2A Q03164 1/20 0.42
NLRP1 Q9C000 1/20 0.42
NOD2 Q9HC29 1/20 0.42
ACHE P22303 1/20 0.41
MMP14 P50281 2/20 0.40
MRGPRX1 Q96LB2 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
HTR1A P08908 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6290387 0.86 SLC6A4 (0.47) SLC6A2SLC6A4SLC6A3ALDH1A1GAA
SCHEMBL6293109 0.86 SLC6A4 (0.47) SLC6A2SLC6A4SLC6A3ALDH1A1GAA
SCHEMBL6289359 0.86 SLC6A4 (0.54) SLC6A2SLC6A4SLC6A3ALDH1A1SMN1; SMN2
SCHEMBL6290694 0.85 SLC6A4 (0.46) SLC6A2SLC6A4SLC6A3ALDH1A1SMN1; SMN2
SCHEMBL6414751 0.83 SLC6A4 (0.47) SLC6A2SLC6A4SLC6A3ALDH1A1GAA
SCHEMBL6289773 0.83 SLC6A4 (0.49) SLC6A2SLC6A4SLC6A3ALDH1A1GAA
SCHEMBL172544 0.83 HTT (0.53) SLC6A2SLC6A4SLC6A3ALDH1A1SMN1; SMN2
SCHEMBL6293850 0.83 SLC6A4 (0.54) SLC6A2SLC6A4SLC6A3ALDH1A1GAA
SCHEMBL6293128 0.82 SMN1; SMN2 (0.58) SLC6A2SLC6A4SLC6A3ALDH1A1SMN1; SMN2
SCHEMBL6290588 0.82 SMN1; SMN2 (0.58) SLC6A2SLC6A4SLC6A3ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 SLC6A2 2617/4885SLC6A4 1103/4885SLC6A3 1638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.